Insulin action impaired by deficiency of the G-protein subunit G ialpha2

Nature
C M Moxham, Craig C Malbon

Abstract

Integration of information between tyrosine kinase and G-protein-mediated pathways is necessary, but remains poorly understood. Here we use cells from transgenic mice harbouring inducible expression of RNA antisense to the gene encoding G ialpha2 to show that G ialpha2 is critical for insulin action. G ialpha2 deficiency in adipose tissue and liver produces hyperinsulinaemia, impaired glucose tolerance and resistance to insulin in vivo. Insulin resistance affects glucose-transporter activity and recruitment, counterregulation of lipolysis, and activation of glycogen synthase, all of which are cardinal responses to insulin. G ialpha2 deficiency increases protein-tyrosine phosphatase activity and attenuates insulin-stimulated tyrosine phosphorylation of IRS (insulin-receptor substrate 1) in vivo. G ialpha2 deficiency creates a model for insulin resistance characteristic of noninsulin-dependent diabetes mellitus (NIDDM), implicating G ialpha2 as a positive regulator of insulin action.

References

Jul 1, 1992·The Journal of Clinical Investigation·J M BoylanP A Gruppuso
Apr 20, 1990·Cell·A Ullrich, J Schlessinger
Sep 1, 1989·The Journal of Clinical Investigation·J MeyerovitchC R Kahn
Dec 15, 1988·The Biochemical Journal·M J King, G J Sale
Jan 1, 1987·Annual Review of Biochemistry·A G Gilman
Jul 1, 1995·Physiological Reviews·G M Reaven
Aug 1, 1994·Biochemical Society Transactions·B E Lavan, G E Lienhard
Jun 1, 1994·Molecular and Cellular Biology·M G MyersM F White

❮ Previous
Next ❯

Citations

Mar 23, 2004·Biochemical and Biophysical Research Communications·Miyuki YamamotoJun Nakura
Jan 20, 2004·Pharmacology & Therapeutics·Nina WettschureckStefan Offermanns
Sep 7, 2000·Biochemical Pharmacology·B P Kennedy, C Ramachandran
Jan 10, 1997·Biochemical Pharmacology·C C Malbon
Jun 12, 2003·Metabolism: Clinical and Experimental·Jason C O'Connor, Gregory G Freund
Mar 14, 2000·Archives of Medical Research·F LarreaA Ulloa-Aguirre
Feb 1, 1997·Cellular Signalling·P CodognoJ J Houri
Nov 1, 1996·Trends in Endocrinology and Metabolism : TEM·M E Patti, C R Kahn
Feb 13, 2001·The International Journal of Biochemistry & Cell Biology·M IshiiT Yamamoto
Mar 1, 1997·The International Journal of Biochemistry & Cell Biology·J J Hsuan, S H Tan
Jan 23, 1998·The International Journal of Biochemistry & Cell Biology·M CurtoM T Rinaudo
Oct 19, 2005·Nature Reviews. Molecular Cell Biology·Craig C Malbon
Jun 24, 2000·British Journal of Pharmacology·R Germack, J M Dickenson
May 13, 1998·Acta Physiologica Scandinavica·F W BoothJ A Carson
Jul 8, 1999·Journal of Internal Medicine·J N Livingston
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ying WangMeisheng Jiang
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·L A VellosoC R Kahn
Jul 7, 2005·Antioxidants & Redox Signaling·Barry J GoldsteinHiroyuki Motoshima
Jul 7, 2005·Antioxidants & Redox Signaling·Joseph L EvansIra D Goldfine
Apr 20, 1999·Neuroreport·S P SinghR Ravindra
Feb 24, 1999·Alcoholism, Clinical and Experimental Research·M RabbaniB Tabakoff
Jun 8, 2000·Annals of the New York Academy of Sciences·M E Patti
Jan 22, 2005·Annual Review of Medicine·Winfried Siffert
Aug 26, 1998·Annual Review of Nutrition·F BoschA Valera
Oct 29, 2009·American Journal of Physiology. Endocrinology and Metabolism·Patrick YuePhilip S Tsao
Apr 15, 2009·Physiology·Mary L EllsworthRandy S Sprague
Dec 31, 1998·American Journal of Respiratory Cell and Molecular Biology·T B KinaneL Ercolani
Apr 29, 1998·The Journal of Clinical Investigation·M E PattiC R Kahn
Apr 23, 1999·Journal of Basic and Clinical Physiology and Pharmacology·M A Rizzo, G Romero
Feb 13, 2001·Biochemical and Biophysical Research Communications·Z G LiG Grunberger
Jan 15, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yumei XiongMasashi Yanagisawa
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·T FischerM G Farquhar
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·C Reynet, C R Kahn
Jun 21, 2014·Experimental & Molecular Medicine·Michelle E KimplePatrick J Casey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.